Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025)

Pulse Biosciences' Change in Receivables history runs 5 years deep, the most recent figure standing at $260000.0 for Q4 2025.

• In Q4 2025, Change in Receivables changed N/A year-over-year to $260000.0; the TTM figure through Dec 2025 stood at $274000.0 (changed N/A YoY), while the FY2025 annual figure was $274000.0, changed N/A from the prior year.
• Change in Receivables was $260000.0 for Q4 2025 at Pulse Biosciences, up from $7000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $260000.0 in Q4 2025 to a low of -$107000.0 in Q2 2023.
• Historically, Change in Receivables has averaged $9166.7 across 5 years, with a median of $2000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables slumped 468.0% in 2022, then surged 600.0% in 2024.
• A 5-year view of Change in Receivables shows it stood at -$11000.0 in 2021, then soared by 54.55% to -$5000.0 in 2022, then soared by 200.0% to $5000.0 in 2023, then slumped by 40.0% to $3000.0 in 2024, then surged by 8566.67% to $260000.0 in 2025.
• The last three Change in Receivables figures came in at $260000.0 (Q4 2025), $7000.0 (Q2 2025), and $7000.0 (Q1 2025), per Business Quant data.